Keyup Listener: window.performance.mark

keyup listener: Some events are more important than others, according to The Independent. If you only have time to focus on a few of the stories about to unfold this week, make sure you don't miss upcoming catalysts for Alnylam ALNY Moderna MRNA and Aimmune Therapeutics AIMT . Here's what to look out for. Search first keyup' ; ; listener ; ;No matching results for ''Tip Try a valid symbol or a specific company name for relevant results Cancel Sign in Mailif window.performance window.performance.mark && && Finance Techif window.performance window.performance.mark && && U.S. Markets open in 4 hrs 23 minsS&P window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && Biotech Stocks That Could Soar This Weekif window.performance window.performance.mark && && Renauer, The Motley Fool Motley Fool September 9, 2019if window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && window.performance window.performance.mark && && biopharmaceutical industry's summer doldrums will unofficially come to a close this week thanks to steady gusts of wind from the Food and Drug Administration, plus a slate of presentations in front of scientists and investors. Three healthcare workers with their thumbs up. Tuesday Alnylam -- how limited Alnylam's first drug to earn approval, Onpattro, is aimed at a very limited population. More Image source Getty Images. (news.financializer.com). As reported in the news.